| Full Name | Lori J Franc |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 34 Years |
| Location | 1909 Vista Dr, Laramie, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275513673 | NPI | - | NPPES |
| 310960 | Other | BCBS | |
| 117805900 | Medicaid | WY | |
| 650024126 | Other | WY | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 707 (Wyoming) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gem City Bone And Joint Pc | 0244144715 | 21 |
News Archive
In order to provide the most effective treatments for cancer patients, it is essential to develop methods of sensitive and specific early detection of the disease. A team of scientists from the NIBRT Dublin-Oxford Glycobiology Laboratory at UCD has developed a system which aims to pinpoint potential "biomarkers" of early forms of the disease.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Unequal exposure to environmental pollutants acting as endocrine-disrupting chemicals is an under-recognized risk factor that may play a key role in driving the higher rates of diabetes among minority and low-income populations, according to a new article in the journal Diabetes Care.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grass-roots special events, has today culminated in MDA providing financial assistance for the start of the first Phase 2 placebo-controlled, multiple dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy.
› Verified 8 days ago
| Provider Name | Gem City Bone & Joint Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366412397 PECOS PAC ID: 0244144715 Enrollment ID: O20031118000791 |
News Archive
In order to provide the most effective treatments for cancer patients, it is essential to develop methods of sensitive and specific early detection of the disease. A team of scientists from the NIBRT Dublin-Oxford Glycobiology Laboratory at UCD has developed a system which aims to pinpoint potential "biomarkers" of early forms of the disease.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Unequal exposure to environmental pollutants acting as endocrine-disrupting chemicals is an under-recognized risk factor that may play a key role in driving the higher rates of diabetes among minority and low-income populations, according to a new article in the journal Diabetes Care.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grass-roots special events, has today culminated in MDA providing financial assistance for the start of the first Phase 2 placebo-controlled, multiple dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lori J Franc, PT 1909 Vista Dr, Laramie, WY 82070 Ph: (307) 745-8851 | Lori J Franc, PT 1909 Vista Dr, Laramie, WY 82070 Ph: (307) 745-8851 |
News Archive
In order to provide the most effective treatments for cancer patients, it is essential to develop methods of sensitive and specific early detection of the disease. A team of scientists from the NIBRT Dublin-Oxford Glycobiology Laboratory at UCD has developed a system which aims to pinpoint potential "biomarkers" of early forms of the disease.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Unequal exposure to environmental pollutants acting as endocrine-disrupting chemicals is an under-recognized risk factor that may play a key role in driving the higher rates of diabetes among minority and low-income populations, according to a new article in the journal Diabetes Care.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grass-roots special events, has today culminated in MDA providing financial assistance for the start of the first Phase 2 placebo-controlled, multiple dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy.
› Verified 8 days ago
Deanna Suder, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1771 Centennial Dr, 220, Laramie, WY 82070 Phone: 307-742-3571 | |
Jeri Black-farber, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1909 Vista Dr, Laramie, WY 82070 Phone: 307-745-8851 Fax: 307-742-0961 | |
Reed L Pedrick, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3125 E Grand Ave, Suite A, Laramie, WY 82070 Phone: 307-742-3110 | |
James Boo, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1575 N 4th St Ste 101, Laramie, WY 82072 Phone: 307-745-5434 | |
Kendra Evans, DPT, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3125 E Grand Ave, Laramie, WY 82070 Phone: 307-742-3110 | |
Michael Zelyez, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1909 Vista Dr, Laramie, WY 82070 Phone: 307-721-8024 |